期刊文献+

小鼠TIE2基因启动子的克隆及转录活性分析 被引量:2

Cloning and Analyzing the Promoter of Mouse TIE2 Gene
下载PDF
导出
摘要 克隆小鼠TIE2基因的启动子并分析其转录活性。设计并合成引物,以小鼠肝脏组织DNA为模板,巢式PCR扩增小鼠TIE2基因启动子区。将扩增获得的系列截短片段克隆入荧光素酶(Luc)报告基因表达载体pGL3-Basic中,构建系列启动子区转录活性报告质粒pGL3-TIE2-Luc。报告质粒与内参质粒共转染SVEC4-10、NIH3T3、HUVEC及NIT-1细胞系,48 h后收获细胞检测双荧光素酶的表达情况。构建的pGL3-TIE2-Luc系列报告质粒经过酶切鉴定及DNA测序分析都显示正确;转染4种细胞系后进行双荧光素酶活性检测的结果表明,TIE2基因启动子区域(-2056-+1)具有较强的转录活性。成功构建小鼠TIE2基因启动子报告质粒,证实TIE2基因上游区域(-2056-+1)具有较强的启动子活性。 It was to clone the promoter of mouse TIE2 gene and analyze the transcription activity.Nest PCRs were used to obtain DNA fragments that contained the promoter of TIE2 gene using genome DNA prepared from mouse liver as the templates.Reporter plasmids pGL3TIE2-Luc contained 5’serial truncated promoter were constructed.After the reporter plasmids were transiently transfected into SVEC410,NIH3T3,HUVEC and NIT-1 cells,the luciferase activity were tested.Result showed that mouse TIE2 promotor fragments were correctly amplified and the reporter plasmids were successfully constructed;Dual luciferase assays of the constructed reporter plasmids in four cell lines showed that the promoter region(-2056-+1)had strong transcriptional activity.Therefore,the promoter of mouse TIE2 gene was successfully cloned.It confirmed that TIE2 promoter region(-2056-+1)had strong transcriptional activity in cell lines.
出处 《生物技术通报》 CAS CSCD 北大核心 2012年第11期90-94,共5页 Biotechnology Bulletin
基金 广西自然科学基金项目(2010GXNSFA013155) 广西医科大学青年自然科学基金项目(304228)
关键词 TIE2 启动子 双荧光素酶活性检测 TIE2 Promoter Dual luciferase assays
  • 相关文献

参考文献12

  • 1罗彦,魏于全.促血管生成素及其受体TEK在血管形成中的调节作用[J].中华医学遗传学杂志,2006,23(1):63-66. 被引量:8
  • 2舒伟,许淑茹,袁志刚.表达Tie2基因的单核细胞研究进展[J].国际免疫学杂志,2010,33(1):5-8. 被引量:2
  • 3王康,尚卫华,贾蓬勃,李徐奇,魏光兵.血管生成素受体Tie2在直肠癌中的表达及作用[J].西安交通大学学报(医学版),2006,27(6):599-601. 被引量:4
  • 4Maisonpierre PC, Suri C,Jones PF, et al. Angiopoietin-2, a natural antagonist for TIE2 that disrupts in vivo angiogenesis. Science, 1997, 277 (5322) : 55-60.
  • 5Shu W, Lin Y, Hua R, et al. Cutaneomucosal venous malformations are linked to the TIE2 mutation in a large Chinese family. Experime?ntal Dermatology, 2012, 21 (6) : 456-457.
  • 6Suri C,Jones PF, Patan S, et aL Requisite role of angiopoietin-l, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 1996,87 (7) : 1171-1180.
  • 7De Palma M, Venneri MA, Hoea C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med, 2003, 9: 789-795.
  • 8Fadel BM, Boutet SC, Quetermous T. Functional analysis of the endothelial cell-specific TIE2/Tek promoter identifies unique protein-binding elements. BiochemJ, 1998,330: 335-343.
  • 9LeiJ, Vodovotz Y, Billiar TR. Endothelial specificity of ICAM2, Flt-I, and TIE2 promoters in vitro and in vivo. InternationalJournal of Biological and Life Sciences, 2007, 3 (2) : 124-128.
  • 10De Palma M, Venneri MA, Galli R, et aL TIE2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 2005, 8: 211-226.

二级参考文献25

  • 1罗彦,文艳君,田聆,吴扬,刘继彦,李秋,李炯,毛咏秋,邓洪新,阚兵,何秋明,杨金亮,魏于全.鸡tie-2受体胞外片段重组蛋白的制备及其抗血管生成作用的研究[J].中华医学遗传学杂志,2004,21(2):101-105. 被引量:4
  • 2邓伟,梁力建.血管生成素及受体和VEGF在人肝细胞癌组织中的表达及作用[J].中国现代医学杂志,2005,15(9):1297-1300. 被引量:5
  • 3高冬玲,郭克民,僧靖静,陈奎生,张云汉.血管生成素-2受体Tie-2在胃癌组织的表达[J].医药论坛杂志,2005,26(20):40-41. 被引量:3
  • 4刘金,蔡荣(审校),钱程(审校).肿瘤基因治疗的策略[J].国际免疫学杂志,2006,29(3):179-184. 被引量:4
  • 5Mantovani A,Allavena P,Sica A. Tumour-associated macrophages as a prototypic type Ⅱ polarised phagocyte population: role in tumour progression. Eur J Cancer,2004,40( 11 ) : 1660-1667.
  • 6Venneri MA, De Palma M, Roca C, et al. Identifi cation of proangiogenic TIE2-expressing monocytes (TEM) in human peripheral blood and cancer. Blood,2007,109(12) :5276-5285.
  • 7De Palma M, Venneri MA, Roca C, et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 2003,9(6) :789-795.
  • 8De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell, 2005,8 ( 3 ) :211-226.
  • 9De Palma M, Mazzieri R, Politi LS, et al. Tumor-targeted interferon-α delivery byTie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell, 2008,14 (4) :299-311.
  • 10Fuchs, EJ. , Whartenby, KA. Hematopoietic stem cell transplantas a platform for tumor immunotherapy. Curr Opin Mol Ther, 2004,6 ( 1 ) :48-53.

共引文献11

同被引文献13

  • 1Rhee KD, :u J, Zhao CY, et al. Dnmtl-dependent DNA methylation is essential for photoreceptor terminal differentiation and retinal neuron survival [ J ]. Cell Death and Disease, 2012 ( 3 ) : e427.
  • 2Feng J, Zhon Y, Campbell SL, et al. Dnmtl and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forcbrain neurons [ J ] . Nat Neurosei, 2010, 13 ( 4 ) : 423-430.
  • 3Klein C J, Botuyan MV, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss [ J ] . Nat Gene, 2011, 43 ( 6 ) : 595-600.
  • 4Winkelmann J, Lin L, Schormair B, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy [ J] . Hum Mol Genet, 2012, 21 : 2205-2210.
  • 5Chung YG, Ratnam S, Chillet JR. Abnormal regulation of DNA methyhransferase expression in cloned mouseembryoa [ J ] . Biol Repro& 2003, 69 ( 1 ) : 146-153.
  • 6Xu YZ, Kanagaratham C, Jancik S, et at. Promoter deletion analysis using a dual-[uciferase reporter system [ J ] . Methods Mol Biol, 2013, 977 : 79-93.
  • 7吴振启,张旭,刘毅,徐华,史涛平,权伟合,李虎宜,张有顺.DNMT1和DNMT3b基因在人膀胱癌组织和细胞中的表达及意义[J].华中科技大学学报(医学版),2009,38(3):321-324. 被引量:5
  • 8宋华梅,黄利鸣,王艳林.哺乳动物DNA甲基转移酶家族的研究进展[J].实用医学杂志,2010,26(5):877-879. 被引量:4
  • 9李光雷,喻树迅,范术丽,宋美珍,庞朝友.表观遗传学研究进展[J].生物技术通报,2011,27(1):40-49. 被引量:33
  • 10祁胜宾,双剑博,卢晓昭,杜建军.人GDDR基因启动子的克隆和报告基因载体构建[J].细胞与分子免疫学杂志,2011,27(2):229-230. 被引量:8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部